• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 4, 2024

    3/4/24 4:53:45 AM ET
    $AKYA
    $AVAV
    $AVDL
    $CARA
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Aerospace
    Industrials
    Get the next $AKYA alert in real time by email

    Companies Reporting Before The Bell

    • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

    • Avadel Pharmaceuticals (NASDAQ:AVDL) is projected to report quarterly loss at $0.29 per share on revenue of $18.11 million.

    • LENSAR (NASDAQ:LNSR) is expected to report quarterly loss at $0.22 per share on revenue of $12.00 million.

    • Sea (NYSE:SE) is projected to report quarterly loss at $0.27 per share on revenue of $3.53 billion.

    • Global Ship Lease (NYSE:GSL) is estimated to report quarterly earnings at $2.35 per share on revenue of $172.02 million.

    • Modiv Industrial (NYSE:MDV) is likely to report earnings for its fourth quarter.

    • GEO Group (NYSE:GEO) is estimated to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • Nektar Therapeutics (NASDAQ:NKTR) is estimated to report quarterly loss at $0.21 per share on revenue of $18.05 million.

    • Ekso Bionics Holdings (NASDAQ:EKSO) is estimated to report quarterly loss at $0.11 per share on revenue of $4.77 million.

    • ContextLogic (NASDAQ:WISH) is likely to report quarterly loss at $2.66 per share on revenue of $53.06 million.

    • Stellus Cap Investment (NYSE:SCM) is expected to report quarterly earnings at $0.45 per share on revenue of $27.41 million.

    • Crawford & Company Common Stock (NYSE:CRD) is expected to report quarterly earnings at $0.20 per share on revenue of $317.48 million.

    • Eos Energy Enterprises (NASDAQ:EOSE) is likely to report quarterly loss at $0.25 per share on revenue of $9.00 million.

    • Southland Holdings (AMEX:SLND) is expected to report quarterly earnings at $0.02 per share on revenue of $274.41 million.

    • Commercial Vehicle Group (NASDAQ:CVGI) is likely to report quarterly earnings at $0.14 per share on revenue of $226.24 million.

    • Paymentus Holdings (NYSE:PAY) is estimated to report quarterly earnings at $0.07 per share on revenue of $157.42 million.

    • Northwest Pipe (NASDAQ:NWPX) is likely to report quarterly earnings at $0.42 per share on revenue of $107.35 million.

    • Crescent Energy (NYSE:CRGY) is estimated to report quarterly earnings at $0.15 per share on revenue of $607.02 million.

    • Stitch Fix (NASDAQ:SFIX) is estimated to report quarterly loss at $0.20 per share on revenue of $330.85 million.

    • Stereotaxis (AMEX:STXS) is expected to report quarterly loss at $0.07 per share on revenue of $7.70 million.

    • SEMrush Hldgs (NYSE:SEMR) is estimated to report quarterly earnings at $0.03 per share on revenue of $83.11 million.

    • Akoya Biosciences (NASDAQ:AKYA) is expected to report quarterly loss at $0.27 per share on revenue of $25.89 million.

    • ThredUp (NASDAQ:TDUP) is likely to report quarterly loss at $0.13 per share on revenue of $80.33 million.

    • AeroVironment (NASDAQ:AVAV) is estimated to report quarterly earnings at $0.33 per share on revenue of $170.62 million.

    • Cara Therapeutics (NASDAQ:CARA) is estimated to report quarterly loss at $0.41 per share on revenue of $9.42 million.

    • GitLab (NASDAQ:GTLB) is expected to report quarterly earnings at $0.08 per share on revenue of $158.21 million.

    • Viant Technology (NASDAQ:DSP) is estimated to report quarterly loss at $0.03 per share on revenue of $65.92 million.

    • Vicarious Surgical (NYSE:RBOT) is expected to report earnings for its fourth quarter.

    • Innovate (NYSE:VATE) is likely to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AKYA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKYA
    $AVAV
    $AVDL
    $CARA

    CompanyDatePrice TargetRatingAnalyst
    Nektar Therapeutics
    $NKTR
    2/10/2026Mkt Perform → Outperform
    William Blair
    Modiv Industrial Inc.
    $MDV
    2/4/2026$18.00Overweight
    Cantor Fitzgerald
    GitLab Inc.
    $GTLB
    1/12/2026$34.00Equal Weight → Underweight
    Barclays
    GitLab Inc.
    $GTLB
    1/12/2026$42.00Overweight → Equal-Weight
    Morgan Stanley
    Crescent Energy Company
    $CRGY
    1/9/2026$10.00Market Perform
    BMO Capital Markets
    GitLab Inc.
    $GTLB
    1/7/2026$40.00Overweight → Neutral
    Cantor Fitzgerald
    AeroVironment Inc.
    $AVAV
    12/19/2025$285.00Overweight
    KeyBanc Capital Markets
    GitLab Inc.
    $GTLB
    12/17/2025$52.00Buy
    BTIG Research
    More analyst ratings

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Director Isaac Paul J bought $66,600 worth of shares (30,000 units at $2.22), increasing direct ownership by 11% to 97,299 units (SEC Form 4)

    4 - Stereotaxis, Inc. (0001289340) (Issuer)

    11/18/25 3:22:17 PM ET
    $STXS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Nova Daniel J bought $522,301 worth of shares (65,000 units at $8.04) (SEC Form 4)

    4 - ThredUp Inc. (0001484778) (Issuer)

    11/6/25 9:06:41 AM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AKYA
    $AVAV
    $AVDL
    $CARA
    SEC Filings

    View All

    SEC Form 424B5 filed by Nektar Therapeutics

    424B5 - NEKTAR THERAPEUTICS (0000906709) (Filer)

    2/10/26 4:24:04 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nektar Therapeutics filed SEC Form 8-K: Regulation FD Disclosure

    8-K - NEKTAR THERAPEUTICS (0000906709) (Filer)

    2/10/26 4:21:41 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    INNOVATE Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    2/10/26 4:08:31 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nektar Therapeutics upgraded by William Blair

    William Blair upgraded Nektar Therapeutics from Mkt Perform to Outperform

    2/10/26 11:48:14 AM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on Modiv with a new price target

    Cantor Fitzgerald initiated coverage of Modiv with a rating of Overweight and set a new price target of $18.00

    2/4/26 8:29:58 AM ET
    $MDV
    Real Estate Investment Trusts
    Real Estate

    GitLab downgraded by Barclays with a new price target

    Barclays downgraded GitLab from Equal Weight to Underweight and set a new price target of $34.00

    1/12/26 8:05:47 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $AKYA
    $AVAV
    $AVDL
    $CARA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)

    4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)

    2/6/26 4:10:10 PM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Asher Daniel claimed ownership of 321,763 shares (SEC Form 3)

    3 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/5/26 6:20:48 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Director Lake Katrina converted options into 8,835 shares and sold $44,232 worth of shares (8,835 units at $5.01) (SEC Form 4)

    4 - Stitch Fix, Inc. (0001576942) (Issuer)

    2/4/26 4:20:09 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Nektar Therapeutics Announces Proposed Public Offering

    SAN FRANCISCO, Feb. 10, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced that it has commenced an underwritten public offering of $300,000,000 of its shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. All of the shares of common stock and pre-funded warrants to be sold in this offering are being offered by Nektar. In addition, Nektar intends to grant the underwriters a 30-day option to purchase up to an additional $45,000,000 of shares of its common stock at the pu

    2/10/26 4:05:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GitLab Transcend Showcases How Intelligent Orchestration Helps Accelerate Innovation Velocity Across the Software Lifecycle

    Keynotes by GitLab Chief Executive Officer Bill Staples and Chief Product and Marketing Officer Manav Khurana highlighted the company's strategy and innovations Customer and partner sessions featured Southwest Airlines® and Oracle Cloud Infrastructure group Demonstrations of AI agents working across the software lifecycle, a virtual hackathon for developers to create custom agents, and a new assessment program to help organizations chart their modernization path for software development All Remote - GitLab Inc., the intelligent orchestration platform for DevSecOps, today hosted GitLab Transcend, an exclusive virtual event for technology leaders highlighting the true potential of a

    2/10/26 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Leadership Updates

    Live Leadership Updates

    View All

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    CVG Announces Appointment of Ari Levy to Board of Directors

    NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Commercial Vehicle Group (the "Company" or "CVG") (NASDAQ:CVGI), a diversified industrial products and services company, today announced that its Board of Directors ("Board") appointed Ari Levy of Lakeview Investment Group ("Lakeview") as an independent director. Lakeview owns approximately 8.9% of the outstanding shares of the Company. In connection with Mr. Levy's appointment, the Board was expanded to 7 members. Mr. Levy will serve on the Board's Nominating, Governance and Sustainability, and Audit Committees. Mr. Levy is the founder, President, and Chief Investment Officer of Lakeview Investment Group, a Chicago based Investment Mana

    2/6/26 4:05:00 PM ET
    $CVGI
    Auto Parts:O.E.M.
    Consumer Discretionary

    Crawford & Company® Announces New Operating Divisions

    Appoints Michael Hoberman CEO of U.S. Operations Crawford & Company® (NYSE:CRD) has announced a new global operating structure designed to accelerate its client-centric strategy to deliver an integrated service model, strengthen collaboration across geographies and enhance the company's ability to deliver unmatched service to clients worldwide. Effective January 1, 2026, Crawford will operate under two divisions – U.S. Operations and International Operations – reflecting a simplified, more client-centric model built for speed, accountability and market responsiveness. Under the new structure, Mike Hoberman has been promoted to CEO of U.S. Operations, reporting to interim Crawford Pres

    1/21/26 4:15:00 PM ET
    $CRD

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Financials

    Live finance-specific insights

    View All

    New REZOLVE-AD Maintenance Data in Atopic Dermatitis Demonstrate Rezpegaldesleukin Resulted in Durable and New Responses Across Key Disease Measurements with Both Monthly and Quarterly Dosing

    71% and 83% of patients maintained EASI-75 responses and 85% and 63% maintained vIGA-AD 0/1 responses with 24 µg/kg monthly and quarterly dosing, respectively Meaningful improvement in responses observed across key efficacy endpoints at week 52 with both monthly and quarterly dosing, including an up to 5-fold increase in EASI-100 response rates Favorable safety profile consistent with previously reported results for rezpegaldesleukin Durability of maintained response rates supports advancement to pivotal Phase 3 program evaluating both monthly and quarterly maintenance dosing Data validate novel first-in-class regulatory T-cell mechanism as a potential best-in-class immune-modulator Confere

    2/10/26 7:00:00 AM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis on February 10, 2026

    SAN FRANCISCO, Feb. 9, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on the development of novel immunology therapies, today announced it will host an investor call and live webcast to review topline results from the 36-week maintenance period of the ongoing Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin, a regulatory T-cell (Treg) proliferator, for moderate-to-severe atopic dermatitis on Tuesday, February 10, 2026 at 8:00 am ET / 5:00 am PT.  Conference Call The results will be provided in a mo

    2/9/26 4:15:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SOHU.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 UNAUDITED FINANCIAL RESULTS

    BEIJING, Feb. 9, 2026 /PRNewswire/ -- Sohu.com Limited (NASDAQ:SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today reported unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter Highlights Total revenues were US$142 million, up 6% year-over-year and down 21% quarter-over-quarter.Marketing services revenues were US$17 million, down 10% year-over-year and up 25% quarter-over-quarter.Online game revenues were US$120 million, up 10% year-over-year and down 26% quarter-over-quar

    2/9/26 12:00:00 AM ET
    $SOHU
    EDP Services
    Technology

    $AKYA
    $AVAV
    $AVDL
    $CARA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Viant Technology Inc.

    SC 13D/A - Viant Technology Inc. (0001828791) (Subject)

    12/6/24 4:08:19 PM ET
    $DSP
    Computer Software: Programming Data Processing
    Technology